Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorM.D. Anderson Cancer Center
About this trial
To track the outcomes of patients who have been treated with RFA and its long-term effectiveness, and to learn more about the quality of life of patients who have received RFA in this study.
Eligibility criteria
Qualifiers
Participants scheduled to undergo ultrasound-guided RFA for the following conditions: benign thyroid nodules, indeterminate thyroid nodules, low-risk DTC, and recurrent PTC
Participant is over 18 years and is either not a surgical candidate or has declined surgery.
Capable and willing to provide written informed consent
Biopsy-proven benign thyroid nodules causing compressive and/or cosmetic symptoms who are requesting treatment,
Disqualifiers
Participants considered unsuitable for RFA by the treating physician
Trial design
Treatments tested in this trial
- Questionnaire
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov